ICL and LASIK correct vision through fundamentally different approaches, and each carries its own set of risks. Neither procedure is categorically “safer” than the other. LASIK reshapes the cornea permanently by removing tissue, while ICL places a removable lens inside the eye without altering the cornea. That distinction drives most of the safety differences between them.
How the Two Procedures Work Differently
LASIK uses a laser to create a thin flap in the cornea, then reshapes the underlying tissue to correct your prescription. The flap is laid back down and heals in place, but the cornea never fully regains its original strength. Studies estimate it recovers only about 2 to 28 percent of its pre-surgery strength in the central region and flap margin. That permanent structural change is the root of LASIK’s unique risks.
ICL (Implantable Collamer Lens) is an additive procedure. A tiny lens is placed behind the iris, in front of your natural lens, through a small incision. No corneal tissue is removed. Because the lens sits inside the eye, ICL introduces a different category of risk: complications related to having a foreign object near your natural lens and the fluid drainage pathways of the eye.
Corneal Risks: LASIK’s Main Vulnerability
The most serious structural risk unique to LASIK is corneal ectasia, a progressive bulging and thinning of the cornea that can severely distort vision. A systematic review found ectasia occurs in roughly 90 per 100,000 eyes after LASIK. That’s about 0.09%, so it’s uncommon, but it’s a permanent complication that may require a corneal transplant in advanced cases. ICL carries no ectasia risk because the cornea is left intact.
Dry eye is the other major corneal concern. LASIK cuts through corneal nerves during flap creation, disrupting the feedback loop that keeps your eyes moist. About 20% of LASIK patients experience chronic dry eye persisting six months or longer after surgery. ICL largely avoids this problem since it doesn’t sever corneal nerves, making it a significantly better option for people already prone to dry eyes.
Internal Eye Risks: ICL’s Trade-Off
Because ICL places a lens inside the eye, it introduces risks that LASIK simply doesn’t have. The most notable is cataract formation. The reported incidence of cataracts within 10 years after ICL implantation is 12.1%, with risk increasing after the seven-year mark. The most common type is anterior subcapsular cataract, which develops from contact or near-contact between the implanted lens and your natural lens. If a cataract does develop, the ICL can be removed and the cataract treated with standard cataract surgery, but it’s still an additional procedure you wouldn’t have needed otherwise.
Elevated eye pressure and secondary glaucoma account for about 4.4% of postoperative complications after ICL. Most of these cases (around 64%) are temporary reactions to steroid eye drops used after surgery, typically resolving within one to four weeks without treatment. The incidence of true secondary glaucoma from other causes like pigment dispersion or pupillary block ranges from 0 to 5%, and onset timing varies. Current ICL models with a small central hole have reduced the rates of pressure spikes, glaucoma, and cataract compared to older designs.
Night Vision and Visual Quality
This is one area where ICL has a clear advantage. A prospective comparison of the two procedures found that simulated night vision improved significantly more with ICL than with LASIK. Contrast sensitivity, your ability to distinguish objects in dim lighting, also improved more after ICL implantation. In fact, ICL did not result in any reported loss of contrast sensitivity at any tested level, while LASIK showed statistically significant worsening of contrast sensitivity across all spatial frequencies.
LASIK can cause glare and halos at night, particularly when the pupil dilates beyond the treated optical zone. ICL’s FDA clinical trial found that night vision problems like halos, glare, and difficulty driving at night either decreased or stayed the same for three years after surgery. Both procedures can produce some visual disturbances, but the data consistently favors ICL for low-light visual quality.
Reversibility
ICL’s biggest safety advantage is that it’s reversible. If complications arise or your prescription changes dramatically, the lens can be removed or exchanged. Over a seven-year period at two surgical centers, about 2% of ICL implants required exchange or removal. In those cases, eye pressure returned to normal and best-corrected visual acuity was preserved. Two patients out of 46 who had their lenses removed developed persistent glaucoma that required ongoing medication, but this was rare.
LASIK is permanent. The tissue removed from your cornea cannot be replaced. Enhancement procedures (a second round of LASIK) are possible for some patients, but they remove additional tissue from an already-thinned cornea, which increases structural risk.
Which Is Better for High Prescriptions
For prescriptions above -6.00 diopters, ICL generally delivers better outcomes. A large cohort study found that the higher the degree of myopia, the greater the visual improvement after ICL surgery. Patients with high myopia (beyond -10.00 diopters) gained an average of 1.5 lines on the eye chart, and 99.6% of highly myopic eyes improved to a low degree of nearsightedness at follow-up.
LASIK becomes less predictable at high prescriptions because correcting severe myopia requires removing more corneal tissue, leaving a thinner, structurally weaker cornea. Most surgeons won’t perform LASIK beyond about -8.00 to -10.00 diopters. ICL can correct prescriptions up to -18.00 or beyond, making it the only refractive option for many people with very high myopia.
Comparing Reoperation Rates
One study tracking both procedures found reoperation rates of 21.4% for ICL and 10.8% for LASIK at one year, though the difference was not statistically significant. ICL reoperations can include lens exchanges for sizing issues or vault adjustments, while LASIK reoperations are typically enhancement procedures for residual prescription. The higher ICL number partly reflects the fact that sizing an internal lens is more complex than programming a laser, and adjustments are sometimes needed to optimize the fit.
How to Think About the Safety Trade-Off
ICL and LASIK don’t compete on the same risk profile. LASIK’s risks are primarily corneal: dry eye, weakened corneal structure, and the small chance of ectasia. ICL’s risks are primarily intraocular: cataracts over time, potential pressure changes, and the general risks of placing a device inside the eye. ICL offers better night vision, full reversibility, and superior outcomes for high prescriptions. LASIK offers a shorter, less invasive procedure with no long-term cataract risk and a decades-long track record.
For moderate myopia in a patient with thick corneas and no dry eye tendency, LASIK’s risk profile is well established and low. For high myopia, thin corneas, or dry eye concerns, ICL’s safety advantages become more pronounced. Your prescription, corneal thickness, eye anatomy, and tolerance for different types of risk all factor into which procedure is genuinely safer for you specifically.